Geode Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-160,461
| Closed | -$3.05M | – | 4301 |
|
|
2019
Q1 | $3.05M | Buy |
160,461
+36,361
| +29% | +$590K | ﹤0.01% | 2599 |
|
|
2018
Q4 | $1.68M | Buy |
124,100
+16,226
| +15% | +$181K | ﹤0.01% | 2857 |
|
|
2018
Q3 | $1.2M | Buy |
+107,874
| New | +$1.08M | ﹤0.01% | 3141 |
|
|
2017
Q1 | – | Sell |
-165,214
| Closed | -$810K | – | 4150 |
|
|
2016
Q4 | $810K | Buy |
165,214
+39,910
| +32% | +$204K | ﹤0.01% | 3093 |
|
|
2016
Q3 | $621K | Buy |
125,304
+1,607
| +1% | +$8.22K | ﹤0.01% | 3165 |
|
|
2016
Q2 | $629K | Buy |
123,697
+1,162
| +0.9% | +$6.26K | ﹤0.01% | 3118 |
|
|
2016
Q1 | $699 | Buy |
122,535
+11,129
| +10% | +$77.7K | ﹤0.01% | 3064 |
|
|
2015
Q4 | $1.16M | Buy |
111,406
+6,334
| +6% | +$86K | ﹤0.01% | 2830 |
|
|
2015
Q3 | $1.94M | Buy |
105,072
+1,415
| +1% | +$27.3K | ﹤0.01% | 2457 |
|
|
2015
Q2 | $2.02M | Buy |
103,657
+819
| +0.8% | +$14.5K | ﹤0.01% | 2499 |
|
|
2015
Q1 | $1.81M | Buy |
102,838
+5,193
| +5% | +$87.2K | ﹤0.01% | 2507 |
|
|
2014
Q4 | $1.56M | Buy |
97,645
+1,865
| +2% | +$25K | ﹤0.01% | 2577 |
|
|
2014
Q3 | $1.21M | Buy |
95,780
+1,325
| +1% | +$18.9K | ﹤0.01% | 2679 |
|
|
2014
Q2 | $1.48M | Buy |
94,455
+3,144
| +3% | +$46.2K | ﹤0.01% | 2569 |
|
|
2014
Q1 | $1.2M | Buy |
91,311
+10,532
| +13% | +$165K | ﹤0.01% | 2666 |
|
|
2013
Q4 | $1.3M | Buy |
80,779
+8,110
| +11% | +$129K | ﹤0.01% | 2554 |
|
|
2013
Q3 | $1.21M | Buy |
72,669
+2,637
| +4% | +$39K | ﹤0.01% | 2493 |
|
|
2013
Q2 | $705K | Buy |
+70,032
| New | +$736K | ﹤0.01% | 2672 |
|
Other funds holding OSIR
Geode Capital Management's OSIR Position: Q2 2019 in Review
Geode Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 160,461 shares — an estimated $3.05M sold.
Geode Capital Management first reported a position in OSIR in Q2 2013 and held it in 18 quarters. The position peaked at $3.05M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.
- Geode Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- Geode Capital Management sold 160,461 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $3.05M.
- Geode Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
- Geode Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $3.05M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.
Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.